Company Filing History:
2 out of 15,471 
1 out of 932 Years Active: 2002-2005
Title: Kirsten Tangemann: Innovator in Glycosyl Sulfotransferase Research
Introduction
Kirsten Tangemann is a notable inventor based in Menlo Park, CA (US). She has made significant contributions to the field of glycosyl sulfotransferase research, holding 2 patents that focus on innovative methods and applications.
Latest Patents
Her latest patents include "Methods of inhibition using glycosyl sulfotransferase-3" and "Method of determining whether an agent modulates glycosyl sulfotransferase-3." These patents describe a novel human glycosylsulfotransferase expressed in high endothelial cells (GST-3) and related polypeptides. The inventions provide nucleic acid compositions encoding these polypeptides, which are useful in various applications, including research, diagnostics, and therapeutic agent screening. Additionally, the patents outline methods for inhibiting selectin-mediated binding events and treating disease conditions associated with GST-3 or KSGal6ST.
Career Highlights
Kirsten has worked with prestigious organizations such as the University of California and Syntex Inc. Her work has significantly advanced the understanding of glycosyl sulfotransferases and their potential therapeutic applications.
Collaborations
Throughout her career, Kirsten has collaborated with esteemed colleagues, including Annette Bistrup and Steven D. Rosen. These collaborations have further enriched her research and contributed to her innovative work.
Conclusion
Kirsten Tangemann's contributions to glycosyl sulfotransferase research exemplify her dedication to innovation in the field. Her patents and collaborations highlight her role as a leading inventor in this important area of study.